Adjuvant Nivolumab Approved in Europe for Completely Resected Stage IIB or IIC Melanoma
OncLive,
Peter Mohr, MD The European Commission has approved single-agent nivolumab (Opdivo) for use in the adjuvant treatment of adult…
Peter Mohr, MD The European Commission has approved single-agent nivolumab (Opdivo) for use in the adjuvant treatment of adult…
This transcript has been edited for clarity. I'm Dr Jeffrey Weber, medical oncologist at the Laura and Isaac Perlmutter Cancer…
Im Onko-Blog dieser Woche berichten wir, dass möglicherweise eine nur systemische Therapie des metastasierten…
There is still a great deal to learn about the optimal use of BRAF-targeted therapy, as well as immunotherapy, in the adjuvant…